![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Spandidos Publications
ISSN: 2049-9469
Source: Molecular and Clinical Oncology, Vol.2, Iss.6, 2014-01, pp. : 909-916
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MUC1 in endometriosis and ovarian cancer
By Vlad Anda Diaconu Iulia Gantt Kira
Immunologic Research, Vol. 36, Iss. 1-3, 2006-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HGF/MET Signaling in Ovarian Cancer
Current Molecular Medicine, Vol. 8, Iss. 6, 2008-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiphospholipid Syndrome and Cancer
Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 2, 2007-04 ,pp. :